eleanor: observing real-life extended adjuvant therapy with neratinib and concurrent use of conkado
Published 2 years ago • 98 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
1:51
eleanor interim analysis: real-world study of adjuvant neratinib in her2 /hr early breast cancer
-
2:34
eleanor: real-world use of neratinib in her2 , early breast cancer
-
1:37
dr. traina on conversations on extended adjuvant therapy with neratinib in her2 breast cancer
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
1:38
unanswered questions in the use of adjuvant therapy in early breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
6:47
extended adjuvant therapy for her2-positive early breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
1:56
exploring extended adjuvant endocrine therapy for hr breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
1:02
results of ember-2: imlunestrant two weeks prior to surgery for er /her2- early stage breast cancer
-
1:24
treatment de-escalation and escalation strategies in her2-positive breast cancer
-
7:23
extended adjuvant therapy in her2-positive disease
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
0:25
copy of dr. shao on managing toxicity with neratinib in her2 breast cancer
-
3:25
role for neratinib following adjuvant dual-targeted her2 therapy